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with hypoplasia or absence of the left ventricle.1
Coarctation of the aorta is usually associated with the
lesion2 and may impede retrograde blood flow to a
H ypoplastic left heart syndrome is a spectrum ofunderdevelopment of the left-sided heart structures,
characterized by aortic valve atresia or severe stenosis
Background: Classic first-stage Norwood repair of hypoplastic left heart
syndrome uses a homograft patch enlargement to obtain an unobstruct-
ed aorta and coronary arteries. Because of possible disadvantages of the
homograft, such as lack of growth, degeneration and calcification, and
availability, we have tried to repair the aorta without patch supplemen-
tation. Methods: Between February 1993 and September 1997, 120
patients, aged birth to 47 days (median 4 days) and weighing 1.7 to 4.4
kg (median 3.1 kg), underwent first-stage palliation for hypoplastic left
heart syndrome. The diameter of the ascending aorta ranged from 1.5 to
8.0 mm (median 3.0 mm). Eight patients had an aberrant right subcla-
vian artery arising from the descending thoracic aorta. In 95 patients
(group I), all duct tissue was excised and the descending aorta was anas-
tomosed to the aortic arch, which had been opened back into the ascend-
ing aorta. Then to this confluence was anastomosed the proximal main
pulmonary artery. In the remaining 25 patients (group II), continuity of
the aortic arch was maintained and the repair was performed with a
Damus-Kaye-Stansel anastomosis. The size of the systemic-to-pul-
monary shunt was 3 mm in 48 patients, 3.5 mm in 70, and 4.0 mm in 2.
Results: Circulatory arrest time ranged from 19 to 105 minutes (median
54 minutes). A homograft patch was necessary for the arch reconstruc-
tion in 18 patients (15%); 9 group I patients (10%) and 9 group II (36%)
(P = .001). There were 82 hospital survivors (68%); 69 group I patients
(73%) and 13 group II (52%) (P = .04), 71 patients without a patch
(70%) and 11 with a patch (61%) (P > .2). By multiple logistic regres-
sion, the aberrant right subclavian artery was a significant risk factor
for hospital death (P = .008). There were 6 late deaths. Sixteen of 71
patients (23%) who underwent second-stage palliation had a neoaortic
arch obstruction develop, with a peak gradient greater than 10 mm Hg;
14 group I patients (23%) and 2 group II (22%) (P > .2), 15 without a
patch (23%) and 1 with a patch (17%) (P > .2). Overall survivals were
57% at 1 year and 55% at 2 years. Conclusion: The modified Norwood
procedure for first-stage palliation of hypoplastic left heart syndrome is
possible in the majority of patients without the use of exogenous mate-
rials and does not result in an increased incidence of neoaortic arch
obstruction. Repair of the aorta without patch supplementation may
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diminutive ascending aorta. Survival after birth depends
entirely on systemic blood flow through a patent ductus
arteriosus and shunting at the atrial level. Without surgi-
cal treatment, practically all infants with this complex
cardiac anomaly die within the first month of life.3,4
Since Norwood, Lang, and Hansen5 first reported suc-
cessful application of a palliative staged approach in
1983, the outlook for the patients with hypoplastic left
heart syndrome has dramatically improved.6,7 Multi-
staged reconstructive surgery, involving the Norwood
procedure followed by bidirectional Glenn and Fontan
operations, is currently the established treatment for
infants with hypoplastic left heart syndrome. However,
stage I palliation still remains a challenging step with a
high mortality. The purpose of the initial palliation is to
create an unobstructed systemic outflow tract from the
right ventricle, together with placement of a systemic-
to-pulmonary shunt. The classic Norwood operation
uses homograft augmentation of the entire aortic arch to
obtain an unobstructed aorta and coronary arteries.8
Possible disadvantages of the homograft, such as lack of
growth, degeneration and calcification, and availability,
stimulated us to construct a neoaorta by a direct anasto-
mosis of the main pulmonary artery to a hypoplastic
ascending and transverse aorta without patch supple-
mentation. Our initial results with developing surgical
techniques to meet this objective have been reported.9
The purpose of the present study was to assess the oper-
ative and intermediate-term results of the modified
Norwood procedure for the first-stage palliation of
hypoplastic left heart syndrome in our first 120 infants.
Patients and methods 
Patient population. Between February 1993 and Sep-
tember 1997, 120 consecutive infants (78 boys and 42 girls)
underwent a first-stage palliation for hypoplastic left heart
syndrome. Hypoplastic left heart syndrome was defined as
left ventricular hypoplasia associated with mitral and aortic
hypoplasia or atresia. The diagnosis was made antenatally in
24 patients. Ten were preterm infants (<37 weeks’ gestation-
al age). Six patients underwent previous interventions,
including balloon aortic valvotomy in 4 patients, balloon atri-
al septostomy in 1, and repair of coarctation of the aorta in 1.
Two patients had chromosomal abnormality: Di George syn-
drome and Turner syndrome.
On arrival at Birmingham Children’s Hospital, all patients
underwent detailed echocardiographic examination. The 120
patients fell into 4 anatomic groups. The largest group of 109
patients (91%) had normally related great arteries, aortic atre-
sia or stenosis, and mitral atresia or stenosis. Six patients
(5%) had double-outlet right ventricle with aortic atresia or
stenosis and mitral atresia or stenosis. Two of these 6 had
severe subaortic stenosis. Four patients (3%) had complete
atrioventricular septal defect with left ventricular hypoplasia
and aortic stenosis. One patient (1%) had dextro-transposition
of the great arteries with a hypoplastic left ventricle, multiple
ventricular septal defects, and aortic and mitral stenosis. The
mean diameter of the ascending aorta was 3.4 ± 1.5 mm
(median = 3.0 mm, range 1.5 to 8.0 mm) and was 2.0 mm or
less in 26 patients. Associated anomalies included an aberrant
right subclavian artery arising from the descending aorta in 8
patients, a left superior vena cava in 6, and partial anomalous
pulmonary venous connection in 1. Any tricuspid or common
atrioventricular valve regurgitation was graded as none, mild,
moderate, or severe by color flow Doppler echocardiography:
mild if the regurgitant jet was detected in less than one third
of the area of the right atrium, moderate if detected in more
than one third but less than two thirds, and severe if detected
in more than two thirds of the right atrium.10 Twenty-five
(21%) patients had mild tricuspid or common atrioventricular
valve regurgitation, 4 (3%) had moderate, and 2 (2%) had
severe regurgitation.
The median age at operation was 4 days, range 5 hours to
47 days, including 57 patients (48%) younger than 40 days
and 6 patients (5%) older than 4 weeks. The mean weight at
operation was 3.2 ± 0.5 kg (median 3.1 kg, range 1.7 to 4.4
kg), and 15 patients (13%) weighed less than 2.5 kg. Sixty
patients (50%) underwent mechanical ventilation before the
operation, and all but 3 patients received an infusion of
alprostadil (prostaglandin El). Forty-six patients (38%) had
moderate to high inotropic support (dobutamine 10 m g/kg per
minute). One infant had acute renal failure necessitating pre-
operative peritoneal dialysis.
Operative technique. Through a midline sternotomy, the
thymus gland was excised. The head vessels were exposed
and looped with tourniquets in preparation for circulatory
Fig 1. The cannulation technique with the arterial cannula
inserted in the proximal main pulmonary artery (MPA) and
the venous cannula inserted in the right atrium (RA). The left
pulmonary artery (LPA) is occluded with a tourniquet, and
there are also tourniquets around the cervical vessels. A poly-
tetrafluoroethylene (PTFE) conduit is being anastomosed to
the right pulmonary artery (RPA). RV, right ventricle.
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arrest. Cardiopulmonary bypass (CPB) was established by
cannulation of the main pulmonary artery and the right atrial
appendage. The branch right and left pulmonary arteries were
immediately occluded and systemic cooling was begun.
During the cooling phase, the ascending aorta was carefully
mobilized and a polytetrafluoroethylene (PTFE) tube* for the
modified right Blalock-Taussig shunt was anastomosed to the
upper border of the right pulmonary artery. At a nasopharyn-
geal temperature of less than 17°C, the circulation was arrest-
ed and the head vessels were snared. Cold crystalloid cardio-
plegic solution (30 mL/kg) was administered from a side port
of the arterial cannula after clamping of the descending tho-
racic aorta. All cannulas were then removed from the heart.
The main pulmonary artery was transected just proximal to
the bifurcation and the distal pulmonary arteries were
Fig 2. A, The dotted lines show the level for transection of the main pulmonary artery (MPA), ductus arteriosus,
descending aorta (D.Ao), and distal aortic arch, and the aortotomy from the aortic arch back down into the ascend-
ing aorta. B, The main pulmonary artery is transected. The patent ductus arteriosus is ligated and transected. All
duct tissue, including the segment of aorta where the coarctation is normally found, is excised. The aortic arch is
opened into the ascending aorta to the level of the proximal main pulmonary artery. PTFE,
Polytetrafluoroethylene; LPA, left pulmonary artery; RPA, right pulmonary artery.
Fig 3. A and B, The descending aorta is anastomosed to the posterior wall of the aortic arch; then to this conflu-
ence is anastomosed the proximal main pulmonary artery. A.Ao, Ascending aorta; D.Ao, descending aorta; MPA,
main pulmonary artery.
*Gore-Tex tube, registered trademark of W. L. Gore & Associates,
Inc, Flagstaff, Ariz.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 117, Number 5
Ishino et al   923
repaired with a direct suture (n = 31), a patch of pulmonary
homograft (n = 40), bovine pericardium (n = 37), or native
pericardium (n = 12). In 95 patients (group I), the descending
thoracic aorta was extensively mobilized by blunt dissection,
without division of intercostal arteries. All duct tissue was
excised from the aorta, thus disconnecting the descending
aorta from the aortic arch. The aortic arch was opened inferi-
orly back down into the ascending aorta to the level of the
transected end of the main pulmonary artery. The back wall
of the descending thoracic aorta was anastomosed to the pos-
terior wall of the aortic arch. The proximal main pulmonary
artery was anastomosed to this confluence, extending the
anastomosis down to the opened out ascending aorta9 (Figs 1
to 4). Among the remaining 25 patients (group II), 14 patients
had an ascending aortic diameter greater than 4.5 mm, 6 had
an aberrant right subclavian artery arising from the descend-
ing aorta, and 5 had coarctation of the transverse aortic arch.
In this group, continuity of the aortic arch was maintained
and the proximal main pulmonary artery was directly anasto-
mosed to the ascending aorta and aortic arch. When undue
tension of the aortic arch and its branch arteries was unavoid-
able, a piece of pulmonary homograft was used to supple-
ment the arch repair in a similar fashion to the classic
Norwood method. The atrial septum was excised, working
through the purse-string suture on the atrial appendage. The
heart was then recannulated, de-aired, clamps were removed,
and the patient was rewarmed to 37°C. During rewarming,
the proximal anastomosis of the modified Blalock-Taussig
shunt was placed on the innominate artery. The size of the
shunt was 3.0 mm in 48 patients, 3.5 mm in 70, and 4.0 mm
Fig 4. After atrial septectomy, the heart is recannulated and
CPB is resumed. During rewarming the proximal anastomo-
sis of the polytetrafluoroethylene shunt is placed on the
innominate artery. D.Ao, Descending aorta; MPA, main pul-
monary artery; RPA, right pulmonary artery; PTFE, polyte-
trafluoroethylene.
Table I. Univariable relations between categoric vari-
ables and hospital death
Hospital death
No. of Odds ratio
Factor patients % (95% CI) P value
Gender
Male 78 32 1.0 (0.4-2.1) .902
Female 42 31
Prematurity
Yes 10 50 2.3 (0.6-8.6) .193
No 110 30
Previous intervention
Yes 6 17 0.4 (0-3.7) .418
No 114 32
Anatomic subtype
AA + MA 49 38 .747
AA + MS 24 38
AS + MA 10 30
AS + MS 37 22
ARSCA
Yes 8 88 18.3 (2.2-154.8) <.001
No 112 28
Left superior vena 
cava
Yes 6 33 1.1 (0.2-6.2) .928
No 114 32
AV valve regurgitation 
(moderate or severe)









Yes 60 28 1.4 (0.6-2.9) .432
No 60 35
Earlier year of 
operation (before 
1996)
Yes 60 32 1.0 (0.5-2.2) 1.000
No 60 32
Surgeon
B.S. 29 41 1.8 (0.7-4.2) .197
W.J.B. 91 29
Type of aortic arch 
repair
Arch continuity (+) 25 48 2.4 (1.0-6.1) .048
Arch continuity (–) 95 27
Patch supplementation 
for arch repair
Yes 18 39 1.5 (0.5-4.1) .475
No 102 30
Size of shunt
3.5 mm 70 34 1.4 (0.6-3.1) .407
3.0 mm 48 27
CI, Confidence interval; AA, aortic atresia; AS, aortic stenosis; MA, mitral atresia;
MS, mitral stenosis; ARSCA, aberrant right subclavian artery; AV, atrioventricular.
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in 2. Continuous 7-0 Prolene suture (Ethicon, Inc,
Somerville, NJ) was used for all anastomoses and interrupted
sutures were not used. Epicardial pacing wires were placed
on the right atrium and ventricle.
Postoperative management. Delayed sternal closure was
used in all patients. At the completion of the operation, the
sternum was left open, a PTFE sheet was sewn to the skin
edges, and dressings were applied. The sternum was closed
on postoperative days 1 to 5 (median, day 2). Inotropic sup-
port was commenced at the time of weaning from CPB. The
most common inotropic agents used were dobutamine 10
m g/kg per minute, dopamine 3 m g/kg per minute, and epi-
nephrine 0.1 m g/kg per minute; occasionally calcium chloride
0.25 mmol/h was also used. Mechanical ventilation with
pressure-regulated neonatal ventilators was adjusted as nec-
essary to maintain arterial oxygen saturations of 70% to 80%,
ventilatory rates (minimum 14 breaths/min) and peak inspi-
ratory pressures (minimum 16 mm Hg) being adjusted to
maintain the arterial carbon dioxide tension between 35 and
45 mm Hg. When the pulmonary vascular resistance
remained low and resultant arterial oxygen saturations were
higher despite minimal ventilatory support, sodium nitro-
prusside was carefully used to reduce systemic vascular resis-
tance. Inspired carbon dioxide and nitrogen were not used to
manipulate the pulmonary vascular resistance in these
patients. Infants with low arterial oxygen saturation (<60%)
resulting from presumed high pulmonary vascular resistance
were managed with alprostadil infusion or inhaled nitric
oxide, or both. Before the child left the intensive care unit,
oral diuretic therapy was routinely instituted. In addition, the
majority of the patients received an angiotensin-converting
enzyme inhibitor for afterload reduction and were discharged
from the hospital on the same medical regimen.
Late management. Elective cardiac catheterization and
echocardiographic examination were performed usually
within 1 to 2 weeks before the second-stage bidirectional
Glenn procedure. Balloon angioplasty of neoaortic arch
obstruction was considered indicated when the pressure gra-
dient across the aortic arch was greater than 10 mm Hg. A
bidirectional Glenn procedure with takedown of the PTFE
shunt was performed via a midline sternotomy with CPB and
hypothermic circulatory arrest, with revision of the neoaorta
or branch pulmonary arteries as necessary.
Statistical methods. The medical records, operative
reports, and echocardiographic results for all patients were
reviewed. Follow-up was complete for all patients. Data were
entered into a computerized database and analyzed with SPSS
software (SPSS Inc, Chicago, Ill) for the Macintosh computer
(Apple Computer Inc, Cupertino, Calif). Hospital deaths were
considered as any deaths during the hospital stay after the
modified Norwood operation, regardless of duration. The data
are presented as the mean ± the standard deviation, and pro-
portional data are presented with their 95% confidence inter-
vals (CI). The Mann-Whitney rank sum test was used for com-
parison of continuous variables in 2 groups. The significance
of categoric variables was analyzed by the c 2 test, unless the
numerator of any proportion had fewer than 5 events, in which
case Fisher’s exact 2-tailed t test was used. To identify the
independent contribution of potential risk factors for hospital
mortality and for development of neoaortic arch obstruction,
we entered variables significant by univariable analysis into a
stepwise multiple logistic regression. The actuarial survival
curve was computed by Kaplan-Meier methods.
Results
One hundred two patients (85%) underwent the mod-
ified Norwood procedure without patch supplementa-
tion for aortic arch reconstruction. A homograft patch
was necessary in 9 group I patients (10%) and 9 group
II patients (36%) (P = .001). The mean circulatory arrest
time was 57 ± 15 minutes (median 54 minutes, range 19
to 105 minutes) and did not differ between groups I and
II (57 ± 13 vs 55 ± 22 minutes, P > .2). Additional sur-
gical procedures at the time of the first-stage palliation
included open aortic valvotomy in 2 patients, repair of
partial anomalous pulmonary venous connection in 1,
and takedown of the modified Blalock-Taussig shunt
because of an unbalanced pulmonary/systemic blood
flow in 4.
There were 82 hospital survivors (68%, 95% CI:
60%-76%), 69 group I patients (73%) versus 13 group
II patients (52%) (P = .04), 71 patients without a patch
(70%) versus 11 with a patch (61%) (P > .2). Thirty-
two patients (84% of the hospital deaths), including 6
patients who could not be weaned from CPB, died
mainly from acute cardiopulmonary collapse within the
first postoperative week. These early deaths occurred in
Table II. Univariable relations between continuous variables and hospital death
Survivors (n = 82) Nonsurvivors (n = 38)
Factor Median Mean Range Median Mean Range P value
Age (d) 4 6 0-41 3 7 0-47 .388
Weight (kg) 3.2 3.2 2.1-4.4 3.1 3.1 1.7-4.1 .359
Ascending aortic diameter (mm) 3.0 3.6 1.5-8.0 2.5 3.1 1.5-8.0 .008
Immediate preop pH 7.41 7.41 7.23-7.62 7.41 7.40 7.13-7.55 .727
Circulatory arrest time (min) 53 54 19-101 59 61 23-105 .015
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22 of 72 patients (31%) with a 3.5 or 4.0 mm shunt and
in 10 of the 48 patients (21%) with a 3.0 mm shunt
(P > .2).
Eleven early reoperations were performed in 9
patients over a range of 5 to 30 days in the immediate
postoperative period, including 1 repeat atrial septecto-
my, 2 operations for relief of a neoaortic arch obstruc-
tion, 2 shunt revisions, and 4 bidirectional Glenn
shunts, which were again converted to modified
Blalock-Taussig shunts in 2 patients. Among the 9
infants undergoing reoperation, there was 1 hospital
death. One child who underwent a successful bidirec-
tional Glenn shunt on day 19 after first-stage palliation
is awaiting completion of the Fontan operation.
Of the variables analyzed as risk factors for hospital
death, diameter of the ascending aorta, origin of an
aberrant right subclavian artery from the descending
aorta, type of aortic arch repair, and circulatory arrest
time were significant when a univariable analysis was
performed (Tables I and II). To assess the simultaneous
effect of categoric and continuous variables, we graded
the diameter of the ascending aorta as 2.0 mm or less,
2.0 to 3.0 mm, 3.0 to 4.0 mm, and greater than 4.0 mm
(P = .022, logistic). The circulatory arrest times were
similarly graded by 10-minute intervals (P = .032,
logistic). The multivariable logistic regression analysis
demonstrated a significant association between the
aberrant right subclavian artery and hospital mortality
(P = .008, odds ratio = 18.0, 95% CI: 2.1-152.5).
Among the 82 discharged patients, there were 6 late
deaths before second-stage palliation. Of the remaining
76 survivors, 71 underwent elective cardiac catheteri-
zation, echocardiographic evaluation, and subsequently
second-stage palliation. Neoaortic arch obstruction
(with a peak gradient greater than 10 mm Hg) con-
firmed by cardiac catheterization was present in 14
patients. Aortic arch obstruction necessitating reopera-
tion had also developed in 2 infants, 8 and 23 days after
first-stage palliation. Thus neoaortic arch obstruction
developed in 16 patients (23%, 95% CI: 13%-32%). Of
these 16 patients, 14 (23%) were in group I and 2
(22%) were in group II (P > .2); 15 of them were with-
out patch supplementation of the aortic arch and 1 had
a patch (P > .2). Univariable analysis did not identify
any significant risk factor for the neoaortic arch
obstruction. The mean peak-to-peak gradient across the
aortic arch in the 16 patients was 27 ± 6 mm Hg (medi-
an 27 mm Hg, range 15-36 mm Hg). The gradient was
less than 20 mm Hg in 3 patients, between 20 and 30
mm Hg in 8, and between 30 and 40 mm Hg in 5. Ten
Fig 5. The current status of all hospital survivors (82/120) after stage I palliative surgery for hypoplastic left heart
syndrome. BDG, Bidirectional Glenn procedure.
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patients underwent successful balloon dilatation of the
coarctation and 6 required surgical repair.
Postoperative tricuspid or common atrioventricular
valve regurgitation assessed by echocardiography was
mild in 22 patients, moderate in 3, and severe in 1.
Forty-three of the 71 patients (61%) had no change in
the degree of tricuspid or common atrioventricular
valve regurgitation, 8 (11%) had improvement, and 20
(28%) had deterioration when findings were compared
with those of the preoperative echocardiogram. Two
patients had moderate neoaortic valve regurgitation.
Seventy-one patients underwent the bidirectional
Glenn shunt after a mean interval of 151 ± 56 days
(median 140 days, range 19-415 days). There was no
difference in the intraoperative interval between
patients with a 3.5-mm or 4.0-mm shunt and those
with a 3.0-mm shunt (155 ± 51 vs 145 ± 63 days, P >
.2). Concomitant procedures at stage II palliation
were as follows: 12 reconstructions of the pulmonary
artery, 4 repairs of the neoaortic arch obstruction, 2
atrial septectomies, 1 repair of the tricuspid valve, and
1 relief of pulmonary vein stenosis. There were 5 hos-
pital deaths and 3 late deaths. To date, the Fontan pro-
cedure has been completed in 3 patients at the ages of
3.5, 4.3, and 3.3 years, and heart transplantation has
been done in 1 patient who had severe tricuspid valve
regurgitation develop after second-stage palliation.
None of these 4 patients died. The current status of all
hospital survivors after the first-stage palliation is
shown in Fig 5.
Actuarial survivals of the 120 patients undergoing the
modified Norwood procedure were 57% (95% CI:
48%-66%) at 1 year and 55% (95% CI: 46%-64%) at 2
years (Fig 6).
Discussion 
Since the introduction of staged surgical palliation
for hypoplastic left heart syndrome by Norwood, Lang,
and Hansen5 in 1983, most centers have adopted their
method of repair. This involves extensive patch
enlargement of the aorta, usually with part of a pul-
monary homograft, to provide an unobstructed outflow
from the right ventricle to the systemic circulation.8 We
were concerned that such an extensive patch placed in
the aorta in the neonatal period would not be able to
grow with the child and might undergo degenerative
changes. In addition, any recoarctation treated by bal-
loon dilatation could be hazardous, with the risk of rup-
ture or false aneurysm formation.11
Interruption of the aorta can be repaired by direct
anastomosis after extensive mobilization of the aortic
arch vessels and descending thoracic aorta.12 It also
seemed possible to extend the Damus-Kaye-Stansel
connection of the pulmonary artery13-15 to the ascend-
Fig 6. Actuarial survival for the entire study group of 120 patients. Vertical bars enclose a 95% confidence interval.
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ing aorta into the aortic arch. A combination of these
two techniques could provide a way of reconstructing
the aorta without the need for patch supplementation.
Additionally, all duct tissue would be removed from the
anastomotic site. Use of only native tissues in the repair
could be advantageous for the future growth and devel-
opment of the aorta. We9 reported our initial experience
with this procedure in 1995, and a similar approach was
reported by Fraser and Mee16 later that year.
In this article we report the attempted application of
this technique for aortic reconstruction to 120 infants
and their early outcome. The hospital survival after
stage I was 68% and the actuarial survival at 2 years,
55%. These results are not dissimilar to other published
survivals of 54% and 76% after stage I repair17,18 and
actuarial survivals of 60% at 2 years in a similarly un-
selected group of patients.18
In 85% of cases we have been able to achieve a direct
aortic anastomosis, with a recoarctation rate in the sur-
vivors of 23%. All recoarctations had catheter-mea-
sured gradients of less than 40 mm Hg. Recoarctation
is not an uncommon problem after this type of opera-
tion, but its true incidence is difficult to assess. Starnes
and colleagues19 reported a recoarctation rate of 33% in
survivors and Bartram and coworkers20 an incidence of
14% in 122 postmortem cases. 
As with other centers, our management of this diffi-
cult group of patients has evolved over the review peri-
od. Initially a 3.5-mm shunt was used,17,18 but in the
later part of the series a 3.0-mm shunt has been pre-
ferred. In our experience this has allowed for a
smoother postoperative course, with fewer episodes of
pulmonary overcirculation. We have not added carbon
dioxide or nitrogen to the postoperative ventilatory
management. Also of note, nonsurvivors in this study
had a smaller ascending aorta than survivors. There
were 14 deaths, comprising 54% of 25 infants with an
ascending aorta of 2.0 mm in diameter or less.
Although this is not a universal finding, others have
made this observation as well.21
The aberrant right subclavian artery arising from the
descending aorta was identified as a risk factor for hos-
pital mortality by multivariable analysis. The distal aor-
tic arch was repaired by the extended end-to-end anas-
tomosis after ligation and division of the aberrant right
subclavian artery in 2 patients, whereas continuity of
the aortic arch was kept in the other 6, regardless of the
existence or not of the aortic coarctation, with only 1
hospital survivor. From a surgical point of view, the
aberrant right subclavian artery prevents an extensive
mobilization of the descending aorta and thus makes
the direct anastomosis between the main pulmonary
artery and aortic arch difficult. Other aspects of man-
agement and our indications for proceeding to the stage
II procedure (bidirectional Glenn) are similar to those
of other centers.18
Although in 85% of cases we have considered it pos-
sible to perform a direct aortic anastomosis, our indi-
cations for patch supplementation have become clear-
er. A very long, diminutive ascending aorta (2.0 mm in
diameter or less), ductus tissue in the aortic arch with
coarctation between the left carotid artery and left sub-
clavian artery, a long ductus arteriosus with a short
descending thoracic aorta, and an aberrant right sub-
clavian artery are contradictions to this modified
repair.
Accurate analysis of the data is difficult because we
cannot provide unbiased patient selection to the two
types of repair. Each surgeon (W.J.B. and B.S.) made
his own assessment of the anatomy and hence the surgi-
cal approach. This assessment changed over the review
period according to experience with the earlier patients.
The small number of patients undergoing the Fontan
procedure during the review period reflects our institu-
tion’s general preference for performing the Fontan
procedure in children older than 3 years of age.
Narrowing of the central pulmonary arteries did
occur in this series, but the incidence and cause have
yet to be analyzed.
In addition, we have not yet been able to analyze the
patients who have died and to fully evaluate their aor-
tic arch reconstruction. Our impression from echocar-
diographic data, their clinical evaluation, and from the
postmortem results so far seen is that the arch repair
has not been any greater problem in those who died.
In conclusion, in the majority of patients (>80%)
with hypoplastic left heart syndrome it is possible to
perform a modified repair of the aorta without patch
supplementation. Hospital survival after stage I repair
and actuarial survival at 2 years are similar to those of
patients undergoing a more classic repair.
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Discussion
Dr Roger B. B. Mee (Cleveland, Ohio). I thoroughly en-
joyed becoming acquainted with the total experience of the
modified Norwood stage I operation from Dr Brawn’s group
in Birmingham, England. Europe has generally been late in
becoming involved in surgery for hypoplastic left heart syn-
drome, and the Birmingham experience of 120 cases dating
from February 1993 to September 1997 may well be the
largest experience in Europe over that period. Apart from the
PTFE shunt, no supplemental patch was used in 85% of
patients for aortic arch reconstruction. 
At the Cleveland Clinic Foundation over a similar period,
we have a significantly smaller experience of 49 patients. The
reasons for using this modification of the Norwood operation
were similar to those of the Birmingham group. Our experi-
ence of 49 patients does differ a little from the Birmingham
experience. We have not used supplemental patches in any
patients. We have avoided cutting down into the very small
ascending aorta, but instead have reimplanted the proximal
aorta in the pulmonary artery root. The early hospital survival
has been 80%, which is not much different from the
Birmingham experience. We have also had the preponderance
of our deaths in those patients with ascending aortas less than
2.0 mm in diameter. On the other hand, small patient size or
the presence of an anomalous right subclavian artery arising
from the descending aorta have not as yet emerged as risk
factors. Perhaps of more interest is the absence of any signif-
icant recurrent arch obstruction. Our operation differs just
slightly from the Birmingham one in that we do cut back the
medial side of the descending aorta and anastomose the prox-
imal main pulmonary to a combination of the descending
aorta, proximal arch, and distal ascending aorta, if it is larger
than 2.0 mm in diameter. Mild stenosis at the origin of the
right or left pulmonary arteries has been moderately common
but easily repaired at the time of the bidirectional cavopul-
monary shunt. Of considerable concern to us with this partic-
ular operation was whether or not the left pulmonary artery
would be compressed by the short neoascending aorta. In
fact, we have not had any cases of left pulmonary artery com-
pression. Dr Brawn, would you comment on whether you
have seen this complication in your series? We thought that
one of the potential advantages of this modification of the
Norwood operation would be a shorter circulatory arrest
time. The transection of the main pulmonary artery and
patching of the distal end have been performed during cool-
ing with the heart beating. In fact, our circulatory arrest time
averages less than 40 minutes for patients in whom the prox-
imal ascending aorta is reimplanted into the right anterior
sinus of the pulmonary valve. 
There is growing concern about the legacy of significant
circulatory arrest times, particularly in patients with
hypoplastic left heart syndrome. Dr Brawn, do you think that
your mean circulatory arrest time of 57 minutes, with an
upper time of 105 minutes, is of significant concern? Are
there any ways in which you think that circulatory arrest time
could be reduced using the Birmingham method? 
I highly commend the Birmingham group’s excellent
reporting of their series and their desire to solve some of the
theoretic problems of the existing Norwood operation.
Dr Brawn. I shall discuss the circulatory arrest time first
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because that is a weak point in the paper. Some of the arrest
times are long, usually when the repair is difficult. We have to
make sure the operation is done accurately. Some of the arrest
times are cumulative, with reperfusion between episodes, but
some of the arrest times are simply long.
Having said that, we are also aware that surgeons are using
circulatory arrest times of similar lengths in neonates for
repair of more straightforward conditions in which biventric-
ular repair is possible. So where does one go in terms of cir-
culatory arrest in the neonate? In the situation of the
hypoplastic left heart syndrome, one has little choice unless
one follows Professor Sano’s suggestion of continuing to pro-
vide antegrade perfusion through the head vessels. We have
not done that. 
As regards left pulmonary artery stenosis, we too were con-
cerned. I illustrated the left pulmonary artery narrowing in the
presentation, because in that particular case the stenoses
seemed to be related to scarring and tethering of the vessel
behind the aorta rather than to any compression. We have
seen severe compression in 1 particular case in which the
patient also had severe tricuspid valve regurgitation and
myocardial failure. That was the 1 patient who underwent
transplantation in this series. 
I understand your method of moving the incision further
down the aorta, and I think I might very well try that. That
technique would be useful to have in one’s armamentarium. I
would be surprised if these complex reconstructions could be
performed without an incidence of recoarctation, and in the
published series of hypoplastic heart repairs it is difficult to
glean what the true incidence of recoarctation is.
I am concerned about the fate of the large patch in the sys-
temic vessel as the child grows into teenage and young adult
life. That may be a false concern, but it is certainly a concern.
This is one of the main reasons for trying to reconstruct the
systemic outflow tract without patch supplementation.
Dr Joseph J. Amato (Chicago, Ill). I congratulate you on
a wonderful series and a superb modification of the Norwood
technique. I learned about this long ago and I tried it several
times. In 2 instances the result was severe stenosis of the left
pulmonary artery, so much so that in 1 patient I had to do a
second shunt on the left pulmonary artery. Have you had to do
that in any of your patients, or have you modified your patch
repair to relieve the stenosis of the left pulmonary artery?
Perhaps you can tell us how to avoid that pitfall.
Dr Brawn. Thank you, sir. It is difficult to avoid. The sizes
of the left and right pulmonary artery always seem to differ,
perhaps in part because we are putting that shunt too far out
to the right. It does seem to me that when we come to the sec-
ond stage that there is always room to enlarge or insert the left
pulmonary artery, even if it is slightly curved, into the roof of
the atrium; it can be displaced. I should also add that at the
time of the first-stage repair we do relieve adventitial attach-
ment so that the left pulmonary artery can have room below
the aorta.
The median age of our patients undergoing the bidirection-
al Glenn procedure is 4 months, and our cardiologists are
asked to be very aggressive in balloon dilating that left pul-
monary artery, if needed after the bidirectional Glenn shunt.
Also at the time of the bidirectional Glenn shunt, we will
repair any pulmonary stenosis as best we can.
Dr Thomas L. Spray (Philadelphia, Pa). One of the
potential advantages of this modification of the Norwood
operation is the avoidance of an incision down into the tiny
ascending aorta. A study from Children’s Hospital in
Philadelphia by Drs Jacobs and Rychik several years ago
showed that flow in the coronary arteries is primarily systolic
after the Norwood operation. Then when the aortopulmonary
shunt is replaced by a venous connection by the hemi-Fontan
or bidirectional Glenn operation, flow in the coronary arter-
ies occurs in diastole. In the case of a tiny ascending aorta, I
wonder whether that transition from systolic to diastolic flow,
in association with any minor limitation of the inflow into the
common coronary, creates ischemia that could account for
some of the sudden deaths after hemi-Fontan operations that
often occur outside the hospital. Could you correlate your
deaths out of hospital or after the hemi-Fontan or bidirec-
tional Glenn procedure with the size of the ascending aorta?
Another question has to do with the aberrant right subcla-
vian artery. When that anomaly is present, generally the
carotid is the first aortic branch and both the carotid and the
ascending aorta are smaller than usual. I noticed that the
shunt sizes that you use are also relatively small. Do you
modify the takeoff of the shunt or use a larger shunt, perhaps
more proximally, in patients who have an aberrant right sub-
clavian artery to be certain that you maintain adequate flow?
Have you been able to identify the causes of death in those
patients with aberrant right subclavian artery, since they seem
to have less favorable outcomes? 
Dr Brawn. You are right. The aberrant right subclavian
arteries have been a big problem; most patients with this
anomaly have died. We have not used a larger shunt, a 3.0-
mm rather than a 3.5-mm shunt recently. When on the odd
occasion we have used a larger shunt, we have had overflow,
and it has been more of a problem than less. We have taken
the view, rightly or wrongly, that if we get a problem with
desaturation, it is not the shunt size but either the runoff or a
technical problem; the angiogram we showed illustrates how
relatively good-sized a shunt it seems to be for the size of the
vessels to which it is attached. 
The size of the ascending aorta is one of our big problems.
Also, it is difficult to be sure that the vessels are not stenos-
ing as the patient grows, that they are not twisting in some
way, and to show anatomically that there is a good pathway
into the small ascending aorta. Our angiography may be not
precise enough to make those determinations, nor is our echo
evaluation. Once we discharge the child to his or her home,
our problem is to try to detect changes in the coronary sup-
ply, which is usually dependent on the size of the ascending
aorta, and if we do detect a change to try do something about
it. We have not been able to do that so far.
Dr William G. Williams (Toronto, Ontario, Canada). This
is a valuable addition to the armamentarium for hypoplastic
left heart syndrome. Personally I find it easier to avoid using
the homograft patch, but my question relates to the few cases
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in which you have used a homograft patch. Could you enlarge
on why you have to do that in some patients?
Dr Brawn. In those instances in which we have had to use
a patch, we have had technical problems with kinking and/or
twisting in the repair. Patching has been a secondary, “fall
back” position. When we have patched with the arch in con-
tinuity, the patch has invariably been very small and has
extended just onto the proximal part of the ascending aorta.
Because we have cut the pulmonary artery quite long, in gen-
eral we have cut back into that patch and then anastomosed
up under the arch. We end up with a main reconstruction of
the new systemic outflow tract being a major pulmonary
artery with very little patch. Thus for various reasons we have
evolved to using a small volume of patch material. 
Commentary
The report by Ishino and associates describes an expe-
rience from Birmingham, England, with what the authors
believe is a modification of the stage I Norwood proce-
dure for hypoplastic left heart syndrome. The procedures
were undertaken between February 1993 and September
1997 with an actuarial survival of 57% at 1 year and 55%
at 2 years. Only 3 of the original 120 patients have suc-
cessfully undergone a Fontan procedure.
Although the authors are correct that the direct anas-
tomosis technique is a modification of the technique
described more recently by Norwood and as applied
presently by many centers undertaking high volumes of
surgery for hypoplastic left heart syndrome, in fact their
technique is essentially identical to the original descrip-
tion of the Norwood procedure as published in The New
England Journal of Medicine in January 1983.1 The rea-
son that Norwood and others abandoned this technique
was because of both early and late arch obstruction, as
well as central distortion of the pulmonary arteries. The
pulmonary artery problem is of course serious in a
patient in whom a Fontan procedure will ultimately be
performed. Central pulmonary artery stenosis is more
likely to occur with this technique, because the main
pulmonary artery must be divided more distally. Also,
the greater tension on the arch anastomosis can lead to
central pulmonary artery compression between the aor-
tic arch and the left main bronchus. Although the cen-
tral pulmonary artery area can be supplemented with a
patch, as described by the authors, nevertheless this
requires a greater rate of growth of the natural pul-
monary artery at this site, since only part of the circum-
ference has growth potential.
Although the early mortality described by the authors
for the stage I procedure is comparable with results
reported from an earlier era, some would argue that a
32% early mortality is relatively high for the era
described in this report. More important, there was sig-
nificant attrition between the first and second stages,
which many groups have found to be due to undetected
arch obstruction. The authors concede that they have not
been able to identify the cause of death in these patients.
Of even greater concern is the high mortality of patients
undergoing the bidirectional Glenn shunt. Many centers
currently describe a mortality for this procedure of less
than 5%, whereas the authors had 5 hospital deaths and
3 late deaths (11%) among their 71 patients undergoing
a stage II procedure. Only 3 patients have successfully
undergone a Fontan procedure.
The authors have stated that their rationale for their
use of the direct anastomosis technique is that an exten-
sive homograft patch in the aorta would not grow and
might undergo degenerative changes. In fact, calcific
degeneration has not proved to be a problem at the cen-
ters that have used this technique for many years,
although certainly a need for balloon dilation and even
stenting of the arch is not uncommon. Surely the same
argument could be applied to the patch plasty of the
pulmonary arteries that the authors have had to use.
However, balloon dilation of the aortic arch is easier
and more likely to be successful than balloon dilation
of the central pulmonary arteries in the patient who has
had a Norwood operation.
In summary, this is an interesting series of patients
with hypoplastic left heart syndrome palliated with the
original stage I Norwood technique. It will be impor-
tant for the authors to report the results of Fontan pro-
cedures in this group of patients, because the ultimate
goal of any stage I procedure is not just to achieve a
stage I survivor, but also to achieve a low-risk Fontan
candidate and subsequent survivor of the Fontan oper-
ation, who has excellent anatomy and hemodynamics.
The authors have not yet achieved this goal.
Richard A. Jonas, MD
Boston, Mass
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